Australian Life Scientist
November 3, 2010 by admin
Filed under Media Reports, Media Reports 2010
| Novotech kicks off Phase Ib trials in Australia and NZ for OncoMed
California-based biopharma company, OncoMed Pharmaceuticals, has announced it will run three Phase Ib clinical trials in Australia and New Zealand testing its humanised monoclonal antibody therapies for cancer. |
For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote #1062  |
